InspireMD (NSPR) EPS (Basic) Growth (3y) (2013 - 2025)
InspireMD (NSPR) EPS (Basic) Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 17.98% |
| 10 | InspireMD | 57.25 Mn | 3.04 Mn | 1.18 Mn | 32.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -24.33% |
| Sep 30, 2025 | 32.51% |
| Jun 30, 2025 | 24.53% |
| Mar 31, 2025 | 26.37% |
| Dec 31, 2024 | -35.70% |
| Sep 30, 2024 | 30.72% |
| Jun 30, 2024 | 20.32% |
| Mar 31, 2024 | 25.78% |
| Dec 31, 2023 | 69.94% |
| Sep 30, 2023 | 43.97% |
| Jun 30, 2023 | 55.86% |
| Mar 31, 2023 | 56.46% |
| Dec 31, 2022 | 67.71% |
| Sep 30, 2022 | 68.70% |
| Jun 30, 2022 | 70.83% |
| Mar 31, 2022 | 78.44% |
| Dec 31, 2021 | 80.42% |
| Sep 30, 2021 | 75.77% |
| Jun 30, 2021 | 84.18% |
| Mar 31, 2021 | 91.27% |